annual CFI:
$165.00M+$276.38M(+248.13%)Summary
- As of today (June 28, 2025), XENE annual cash flow from investing activities is $165.00 million, with the most recent change of +$276.38 million (+248.13%) on December 31, 2024.
- During the last 3 years, XENE annual CFI has risen by +$411.77 million (+166.86%).
- XENE annual CFI is now at all-time high.
Performance
XENE Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$34.51M-$63.99M(-64.97%)Summary
- As of today (June 28, 2025), XENE quarterly cash flow from investing activities is $34.51 million, with the most recent change of -$63.99 million (-64.97%) on March 31, 2025.
- Over the past year, XENE quarterly CFI has increased by +$77.70 million (+179.90%).
- XENE quarterly CFI is now -67.96% below its all-time high of $107.71 million, reached on June 30, 2024.
Performance
XENE quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$242.70M+$77.70M(+47.09%)Summary
- As of today (June 28, 2025), XENE TTM cash flow from investing activities is $242.70 million, with the most recent change of +$77.70 million (+47.09%) on March 31, 2025.
- Over the past year, XENE TTM CFI has increased by +$443.90 million (+220.63%).
- XENE TTM CFI is now at all-time high.
Performance
XENE TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
XENE Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +248.1% | +179.9% | +220.6% |
| 3 y3 years | +166.9% | +170.6% | +200.9% |
| 5 y5 years | +349.2% | +165.2% | +316.4% |
XENE Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +156.2% | -68.0% | +114.4% | at high | +148.8% |
| 5 y | 5-year | at high | +156.2% | -68.0% | +114.4% | at high | +148.8% |
| alltime | all time | at high | +156.2% | -68.0% | +114.4% | at high | +148.8% |
XENE Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $34.51M(-65.0%) | $242.70M(+47.1%) |
| Dec 2024 | $165.00M(-248.1%) | $98.50M(+4874.9%) | $165.00M(-195.2%) |
| Sep 2024 | - | $1.98M(-98.2%) | -$173.29M(+42.8%) |
| Jun 2024 | - | $107.71M(-349.4%) | -$121.39M(-39.7%) |
| Mar 2024 | - | -$43.19M(-82.0%) | -$201.20M(+80.6%) |
| Dec 2023 | -$111.39M(-62.0%) | -$239.79M(-545.0%) | -$111.39M(-195.5%) |
| Sep 2023 | - | $53.88M(+93.1%) | $116.67M(-168.1%) |
| Jun 2023 | - | $27.90M(-40.2%) | -$171.31M(-13.4%) |
| Mar 2023 | - | $46.62M(-497.2%) | -$197.90M(-32.6%) |
| Dec 2022 | -$293.40M(+18.9%) | -$11.74M(-95.0%) | -$293.40M(-41.0%) |
| Sep 2022 | - | -$234.10M(<-9900.0%) | -$497.10M(+100.9%) |
| Jun 2022 | - | $1.32M(-102.7%) | -$247.43M(+2.9%) |
| Mar 2022 | - | -$48.89M(-77.3%) | -$240.55M(-2.5%) |
| Dec 2021 | -$246.77M(+1366.8%) | -$215.43M(-1483.2%) | -$246.77M(-2180.3%) |
| Sep 2021 | - | $15.57M(+90.1%) | $11.86M(-154.6%) |
| Jun 2021 | - | $8.19M(-114.9%) | -$21.75M(+14.4%) |
| Mar 2021 | - | -$55.10M(-227.6%) | -$19.00M(+13.0%) |
| Dec 2020 | -$16.82M(-74.6%) | $43.20M(-339.6%) | -$16.82M(-86.0%) |
| Sep 2020 | - | -$18.03M(-264.9%) | -$120.34M(+27.3%) |
| Jun 2020 | - | $10.93M(-120.7%) | -$94.57M(-15.7%) |
| Mar 2020 | - | -$52.92M(-12.3%) | -$112.13M(+69.4%) |
| Dec 2019 | -$66.21M | -$60.32M(-879.3%) | -$66.21M(+258.9%) |
| Sep 2019 | - | $7.74M(-216.8%) | -$18.45M(-62.8%) |
| Jun 2019 | - | -$6.63M(-5.4%) | -$49.53M(+20.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$7.00M(-44.2%) | -$40.97M(+41.3%) |
| Dec 2018 | -$28.99M(-219.3%) | -$12.56M(-46.2%) | -$28.99M(+172.7%) |
| Sep 2018 | - | -$23.35M(-1303.5%) | -$10.63M(-184.1%) |
| Jun 2018 | - | $1.94M(-61.0%) | $12.63M(-36.9%) |
| Mar 2018 | - | $4.98M(-14.2%) | $20.02M(-17.6%) |
| Dec 2017 | $24.29M(-150.8%) | $5.80M(-6620.2%) | $24.29M(-276.9%) |
| Sep 2017 | - | -$89.00K(-101.0%) | -$13.73M(-0.2%) |
| Jun 2017 | - | $9.33M(+0.9%) | -$13.76M(-64.3%) |
| Mar 2017 | - | $9.25M(-128.7%) | -$38.51M(-19.5%) |
| Dec 2016 | -$47.84M(-569.3%) | -$32.23M(>+9900.0%) | -$47.84M(+203.6%) |
| Sep 2016 | - | -$111.00K(-99.3%) | -$15.76M(+127.1%) |
| Jun 2016 | - | -$15.42M(>+9900.0%) | -$6.94M(-180.5%) |
| Mar 2016 | - | -$83.00K(-42.0%) | $8.62M(-15.4%) |
| Dec 2015 | $10.19M(-414.2%) | -$143.00K(-101.6%) | $10.19M(-10.4%) |
| Sep 2015 | - | $8.71M(+6256.9%) | $11.38M(-515.1%) |
| Jun 2015 | - | $137.00K(-90.8%) | -$2.74M(+93.7%) |
| Mar 2015 | - | $1.49M(+43.4%) | -$1.42M(-56.4%) |
| Dec 2014 | -$3.24M(-71.7%) | $1.04M(-119.2%) | -$3.24M(-24.3%) |
| Sep 2014 | - | -$5.41M(-469.7%) | -$4.28M(-480.8%) |
| Jun 2014 | - | $1.46M(-532.8%) | $1.13M(-432.8%) |
| Mar 2014 | - | -$338.00K | -$338.00K |
| Dec 2013 | -$11.47M(-2436.5%) | - | - |
| Dec 2012 | $491.00K(-96.5%) | - | - |
| Dec 2011 | $13.89M | - | - |
FAQ
- What is Xenon Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual CFI year-on-year change?
- What is Xenon Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly CFI year-on-year change?
- What is Xenon Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals TTM CFI year-on-year change?
What is Xenon Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of XENE is $165.00M
What is the all time high annual CFI for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual cash flow from investing activities is $165.00M
What is Xenon Pharmaceuticals annual CFI year-on-year change?
Over the past year, XENE annual cash flow from investing activities has changed by +$276.38M (+248.13%)
What is Xenon Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of XENE is $34.51M
What is the all time high quarterly CFI for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly cash flow from investing activities is $107.71M
What is Xenon Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, XENE quarterly cash flow from investing activities has changed by +$77.70M (+179.90%)
What is Xenon Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of XENE is $242.70M
What is the all time high TTM CFI for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high TTM cash flow from investing activities is $242.70M
What is Xenon Pharmaceuticals TTM CFI year-on-year change?
Over the past year, XENE TTM cash flow from investing activities has changed by +$443.90M (+220.63%)